
24065-33-6 5-chlorothiophene-2-carboxylic Acid
CAS:24065-33-6. MF:C5H3ClO2S. MW:162.59. EINECS:000-000-0. MDL No.:MFCD00041426
Add to Inquiry
CAs 13726-14-2 | 4-Chloro-3-methoxyaniline
Name: 4-Chloro-3-methoxyanilineCAS number: 13726-14-2Molecular formula: C7H8ClNOMolecular weight: 157.6EINECS number:MDL No.:MFCD00672967
Add to Inquiry
CAS 1428243-26-8 | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester
Product name: (3R, 4S) -3- (2-Bromoacetyl) -4-ethyl-1-pyrolidinecarboxylic acid phenylmethyl esterCAS number: 1428243-26-8Molecular formula: C16H20BrNO3Molecular weight: 354.24EINECS number:MDL
Add to Inquiry
505-54-4 HEXADECANEDIOIC ACID
Product name: HEXADECANEDIOIC ACIDCAS number: 505-54-4Molecular formula: C16H30O4Molecular weight: 286.41EINECS number: 208-013-5MDL No.:MFCD00002746
Add to Inquiry
90-33-5 4-Methylumbelliferone
Product name: 4-MethylumbelliferoneCAS number: 90-33-5Molecular formula: C10H8O3Molecular weight: 176.17EINECS number: 201-986-7MDL No.:MFCD00006866
Add to Inquiry
871-70-5 OCTADECANEDIOIC ACID
Product name: OCTADECANEDIOIC ACIDCAS number: 871-70-5Molecular formula: C18H34O4Molecular weight: 314.46EINECS number: 442-490-2MDL No.:MFCD00142369
Add to Inquiry
683239-16-9 20-(tert-Butoxy)-20-oxoicosanoic
Product name: 20-(tert-Butoxy)-20-oxoicosanoicCAS number: 683239-16-9Molecular formula: C24H46O4Molecular weight: 398.62EINECS number:MDL No.:MFCD23136041
Add to Inquiry
303-26-4 1-(4-chlorobenzhydryl)piperazine
Product name:1-(4-chlorobenzhydryl)piperazineCAS:303-26-4. MF:C17H19ClN2. MW:286.8. EINECS:206-137-4. MDL No.:MFCD00005965
Add to Inquiry
641569-94-0 Nilotinib Intermediate
Product name:Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acidCAS:641569-94-0. MF:C17H14N4O2. MW:306.32. EINECS:629-968-8. MDL No.:MFCD11521324
Add to Inquiry
608141-42-0 2-(methylsulfonyl)ethanamine
CAS:608141-42-0. MF:C12H19NO4S. MW:273.35. EINECS:807-236-0. MDL No.:MFCD22677268
Add to Inquiry
161596-47-0 N-(s)-glycidylphthalimide
CAS:161596-47-0. MF:C11H9NO3. MW:203.19. EINECS:454-720-9. MDL No.:MFCD04973350
Add to Inquiry
138642-62-3 2-cyanophenylboronic Acid
Product name:2-cyanophenylboronic AcidCAS:138642-62-3. MF:C7H6BNO2. MW:146.94. EINECS:604-090-8. MDL No.:MFCD01632208
Add to Inquiry
China Olaparib intermediate Manufacturers Factory Suppliers
With our professionalism in the business of mainstream product intermediate, minor intermediate, alternative intermediate we have continuously achieved exciting results. Adhering to the business philosophy of 'customer first, forge ahead', excellent quality and perfect service are our constant promise.Our current challenge is to do everything we can to facilitate getting our Olaparib intermediate to market, starting and expanding new businesses, and training and hiring new employees. We believe that our efforts will improve the performance of our products, reduce the cost of use, and bring direct benefits to our customers. Our team of experts is committed to delivering efficient, cost-effective solutions that maximize our clients’ return on investment. The company strives to improve product competitiveness and advocates the business philosophy of "excellent quality, considerate service, surpass the present, and strive for perfection". With strong strength and broad mind, the company has gathered many professional elites who are responsible and effective in management. We have established a deep and distinctive brand image, with unique innovation, research and development capabilities, and are committed to providing customers and partners with high brand value-added products, technologies and services. We embrace diversity and inclusivity in our workplace and society. We hope to use safety culture to lead all work of safety production, and use safety culture to create corporate safety shields.WEBSep 15, 2021 · Preparation method of olaparib intermediate. Abstract. The invention discloses a method for preparing an olaparib key intermediate compound as shown in...
WEBMay 10, 2019 · In this study, the ORR of veliparib monotherapy in patients with gBRCA1/2-mutated, platinum-resistant or intermediate-sensitive (disease relapse within 6 to 12...
WEBFeb 11, 2022 · Olaparib (Lynparza) is a potent, highly selective inhibitor of poly (ADP-ribose)polymerase enzymes, approved by the U.S. FDA and EMA for the treatment of...
WEBAug 9, 2017 · Olaparib, rucaparib, and niraparib are three inhibitors of poly (ADP-ribose) polymerase (PARP) enzymes that have been recently approved for the treatment of...
WEBIndication: In combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with deleterious or suspected deleterious germline and/or somatic...
WEBFeb 2, 2022 · Olaparib (Lynparza) is a potent, highly selective inhibitor of poly(ADP-ribose)polymerase enzymes, approved by the U.S. FDA and EMA for the treatment of...
